Impact analysis of COVID-19 on Cancer Screening Global Market Outlook 2027

  • Product Code:
    RP-ID-10324792
  • Published Date:
    25 Jun 2020
  • Region:
    Global
  • Pages:
    554
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-9

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

Cancer Screening Market Analysis – 2019-2027

According to the World Health Organization, the global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018.Cancer screening tests are diagnostic procedures that are done in order to identify cancer in the body and therefore reduce the number of people who develop cancer or reach the later stages of cancer where it becomes untreatable. These tests can help to detect cancer at its early stages, where it may be easier to treat. The market for cancer screening is anticipated to grow at a significant CAGR of around 9.67% over the forecast period, i.e., 2020-2027.
The market is segmented by diagnostic methods, by cancer, by end user and by region. Based on the diagnostic methods, the market for cancer screening is segmented into genetic tests, instrument based tests and platform based tests. Out of these, the segment for instrument based tests is is anticipated to attain a market size of around USD 177,978 million by the year 2027 and is projected to grow with a significant CAGR over the forecast period. This segment is further divided into imaging tests, endoscopy procedures and biopsy, out of which, the segment for imaging tests is predicted to hold the leading share in the market on account of rising demand for minimally invasive procedures globally.
On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market in North America is anticipated to hold the leading share over the forecast period. The growth in the region can be attributed to the increase in investments towards healthcare from government and private entities in order to maintain the highest quality of care offered in healthcare facilities. Further, the market in Asia Pacific region is anticipated to grow with the highest CAGR of 11.12% over the forecast period on account of demand for new and improved technology and treatment methods from China. With the rising availability of advanced healthcare in Asia Pacific along with growing number of manufacturers investing in countries such as China, Japan, & India, the demand for cancer screening products in this region is estimated to witness a rapid growth in the coming years.
Some of the key industry leaders in the global cancer screening market are Siemens Healthineers AG, GE Healthcare, Abbott, F. Hoffmann-La Roche Ltd., Olympus Corporation, FUJIFILM Corporation, Agilent Technologies, Inc. and Thermo Fisher Scientific.
Global Cancer Screening Market
1. Introduction
1.1. Market Definition
1.2. Market Segmentation
1.3. Product Overview
2. Assumptions And Acronyms
3. Research Methodology
4. Executive Summary - Global Cancer Screening Market
5. Regulatory Landscape
6. Epidemiology Analysis
7. Market Dynamics
7.1. Growth Drivers
7.2. Restraints
7.3. Key Trends
7.4. Opportunities
8. Key Manufacturers
9. Recent Technological Advancements
10. Cancer Screening Market - Risk Analysis
10.1. Demand Risk Analysis
10.2. Supply Risk Analysis
11. Global Cancer Screening Market Outlook

11.1. Market Size And Forecast, 2019-2027
11.1.1. By Value (Usd Million)
11.2. Global Cancer Screening Market Segmentation, 2019-2027
· By Diagnostic Method
V Genetic Tests: Brca Tests, Her2 Tests, Ca-125 Test Kras Mutation Tests, Alpha-Fetoprotein (Afp) Test, Ca-19 Radioimmunoassay Tests, Immunoglobulins Test, Chromogranin A (Cga) Tests, Others, 2019-2027f (Usd Million)
V Instrument Based Tests: Imaging Tests, Endoscopy Procedures & Biopsy, 2019-2027f (Usd Million)
Ø Imaging Tests: X-Rays, Computed Tomography (Ct), Magnetic Resonance Imaging (Mri), Positron Emission Tomography, Ultrasound & Mammography, 2019-2027f (Usd Million)
Ø Endoscopy Procedures: Bronchoscopy, Colonoscopy, Cystoscopy, Laparoscopy, Thoracoscopy & Others, 2019-2027f (Usd Million)
Ø Biopsy: Needle Biopsy, Bone Marrow Biopsy, Punch Biopsy, Skin Biopsy, Shave Biopsy & Others, 2019-2027f (Usd Million)
V Platform Based Tests: Immunohistochemistry, Next-Generation Sequencing, Pcr, Microarrays, Flow Cytometry, In-Situ Hybridization & Others, Chromogranin A (Cga) Tests & Others, 2019-2027f (Usd Million)
· By Type Of Cancer
V Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Liver Cancer, Pancreatic Cancer, Skin Cancer, Cervical Cancer & Others, 2019-2027f (Usd Million)
· By End User
V Hospitals, Oncology Clinics, Diagnostic Centers And Others, 2019-2027f (Usd Million)
11.3. Global Cancer Screening Market Segmentation- By Region
§ North America Cancer Screening Market, 2019-2027f (Usd Million)
Ø Market Overview
Ø Market Size, 2019-2027f (Usd Million)
Ø Market Segmentation
· By Diagnostic Method
· By Type Of Cancer
· By End User
· By Country
§ Europe Cancer Screening Market, 2019-2027f (Usd Million)
Ø Market Overview
Ø Market Size, 2019-2027f (Usd Million)
Ø Market Segmentation
· By Diagnostic Method
· By Type Of Cancer
· By End User
· By Country
§ Asia Pacific Cancer Screening Market, 2019-2027f (Usd Million)
Ø Market Overview
Ø Market Size, 2019-2027f (Usd Million)
Ø Market Segmentation
· By Diagnostic Method
· By Type Of Cancer
· By End User
· By Country
§ Latin America Cancer Screening Market, 2019-2027f (Usd Million)
Ø Market Overview
Ø Market Size, 2019-2027f (Usd Million)
Ø Market Segmentation
· By Diagnostic Method
· By Type Of Cancer
· By End User
· By Country
§ Middle East & Africa Cancer Screening Market, 2019-2027f (Usd Million)
Ø Market Overview
Ø Market Size, 2019-2027f (Usd Million)
Ø Market Segmentation
· By Diagnostic Method
· By Type Of Cancer
· By End User
· By Country
12. Competitive Structure
12.1. Detailed Overview
12.2. Assessment Of Key Product Offerings
12.3. Analysis Of Growth Strategies
12.4. Key Collaborations And Joint Ventures
12.5. Key Mergers And Acquisitions
12.6. Recent News And Developments
12.7. Key Clients And Partners
12.8. Exhaustive Analysis On Key Financial Indicators
12.9. Company Profiles Of Global Cancer Screening Market
12.9.1. Roche
12.9.2. Abbott
12.9.3. Fujifilm
12.9.4. Siemens Healthineers
12.9.5. Ge Healthcare
12.9.6. Thermo Fisher Scientific
12.9.7. Olympus Corporation
12.9.8. Agilent
12.9.9. Other Market Players
13. Strategic Recommendations
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
Siemens Healthineers AG, GE Healthcare, Abbott, F. Hoffmann-La Roche Ltd., Olympus Corporation, FUJIFILM Corporation, Agilent Technologies, Inc. and Thermo Fisher Scientific
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports